Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 284

1.

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.

Qin T, Zhang Y, Zarins KR, Jones TR, Virani S, Peterson LA, McHugh JB, Chepeha D, Wolf GT, Rozek LS, Sartor MA.

Sci Rep. 2018 Jul 30;8(1):11458. doi: 10.1038/s41598-018-29599-w.

2.

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

Wolf GT, Moyer JS, Kaplan MJ, Newman JG, Egan JE, Berinstein NL, Whiteside TL.

Onco Targets Ther. 2018 Jun 28;11:3731-3746. doi: 10.2147/OTT.S165411. eCollection 2018. Review.

3.

Redefining Perineural Invasion: Integration of Biology With Clinical Outcome.

Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf GT, Taylor JMG, D'Silva NJ.

Neoplasia. 2018 Jul;20(7):657-667. doi: 10.1016/j.neo.2018.04.005. Epub 2018 May 23.

4.

Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.

Tan YS, Sansanaphongpricha K, Xie Y, Donnelly CR, Luo X, Heath BR, Zhao X, Bellile E, Hu H, Chen H, Polverini PJ, Chen Q, Young S, Carey TE, Nör JE, Ferris RL, Wolf GT, Sun D, Lei YL.

Clin Cancer Res. 2018 Sep 1;24(17):4242-4255. doi: 10.1158/1078-0432.CCR-17-2807. Epub 2018 May 16.

PMID:
29769207
5.

Vitamin D intake and survival and recurrence in head and neck cancer patients.

Yokosawa EB, Arthur AE, Rentschler KM, Wolf GT, Rozek LS, Mondul AM.

Laryngoscope. 2018 May 14. doi: 10.1002/lary.27256. [Epub ahead of print]

PMID:
29756240
6.

Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.

Berinstein NL, McNamara M, Nguyen A, Egan J, Wolf GT.

Oncoimmunology. 2018 Feb 21;7(5):e1423173. doi: 10.1080/2162402X.2017.1423173. eCollection 2018.

7.

Retraction notice to: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents.

Ali S, Varghese L, Pereira L, Tulunay-Ugur OE, Kucuk O, Carey TE, Wolf GT, Sarkar FH.

Cancer Lett. 2018 Jun 1;423:154. doi: 10.1016/j.canlet.2018.03.018.

8.

Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study.

Arthur AE, Goss AM, Demark-Wahnefried W, Mondul AM, Fontaine KR, Chen YT, Carroll WR, Spencer SA, Rogers LQ, Rozek LS, Wolf GT, Gower BA; University of Michigan Head and Neck SPORE Program.

Int J Cancer. 2018 Sep 1;143(5):1105-1113. doi: 10.1002/ijc.31413. Epub 2018 Apr 17.

PMID:
29604042
9.

Reply to L. Licitra et al.

Forastiere AA, Fisher SG, Wolf GT.

J Clin Oncol. 2018 May 1;36(13):1377-1378. doi: 10.1200/JCO.2018.77.8316. Epub 2018 Mar 20. No abstract available.

PMID:
29558279
10.

Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.

Tan YS, Sansanaphongpricha K, Prince MEP, Sun D, Wolf GT, Lei YL.

J Dent Res. 2018 Jun;97(6):627-634. doi: 10.1177/0022034518764416. Epub 2018 Mar 13.

PMID:
29533731
11.

Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME.

Oral Oncol. 2018 Feb;77:83-89. doi: 10.1016/j.oraloncology.2017.12.003. Epub 2017 Dec 23.

PMID:
29362129
12.

Head and neck paragangliomas: A two-decade institutional experience and algorithm for management.

Smith JD, Harvey RN, Darr OA, Prince ME, Bradford CR, Wolf GT, Else T, Basura GJ.

Laryngoscope Investig Otolaryngol. 2017 Nov 11;2(6):380-389. doi: 10.1002/lio2.122. eCollection 2017 Dec.

13.

Hypothyroidism and Wound Healing After Salvage Laryngectomy.

Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME.

Ann Surg Oncol. 2018 May;25(5):1288-1295. doi: 10.1245/s10434-017-6278-4. Epub 2017 Dec 20.

PMID:
29264671
14.

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Forastiere AA, Ismaila N, Wolf GT.

J Oncol Pract. 2018 Feb;14(2):123-128. doi: 10.1200/JOP.2017.027912. Epub 2017 Nov 27. No abstract available.

PMID:
29172913
15.

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Forastiere AA, Ismaila N, Lewin JS, Nathan CA, Adelstein DJ, Eisbruch A, Fass G, Fisher SG, Laurie SA, Le QT, O'Malley B, Mendenhall WM, Patel S, Pfister DG, Provenzano AF, Weber R, Weinstein GS, Wolf GT.

J Clin Oncol. 2018 Apr 10;36(11):1143-1169. doi: 10.1200/JCO.2017.75.7385. Epub 2017 Nov 27.

PMID:
29172863
16.

Individualized outcome prognostication for patients with laryngeal cancer.

Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG.

Cancer. 2018 Feb 15;124(4):706-716. doi: 10.1002/cncr.31087. Epub 2017 Nov 7.

PMID:
29112231
17.

Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.

Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME.

Head Neck. 2017 Dec;39(12):2512-2518. doi: 10.1002/hed.24918. Epub 2017 Sep 30.

PMID:
28963806
18.

Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.

Zhang H, Kim S, Chen Z, Nannapaneni S, Chen AY, Moore CE, Sica G, Mosunjac M, Nguyen MLT, D'Souza G, Carey TE, Peterson LA, McHugh JB, Graham M, Komarck CM, Wolf GT, Walline HM, Bellile E, Riddell J 4th, Pai SI, Sidransky D, Westra WH, William WN Jr, Lee JJ, El-Naggar AK, Ferris RL, Seethala R, Grandis JR, Chen ZG, Saba NF, Shin DM; Head and Neck Cancer SPORE HIV supplement consortium.

Head Neck. 2017 Dec;39(12):2433-2443. doi: 10.1002/hed.24911. Epub 2017 Sep 25.

PMID:
28945296
19.

HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.

Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek LS, Sartor MA.

Mol Cancer Res. 2018 Jan;16(1):90-102. doi: 10.1158/1541-7786.MCR-17-0153. Epub 2017 Sep 19.

PMID:
28928286
20.

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

de Bree R, Wolf GT, de Keizer B, Nixon IJ, Hartl DM, Forastiere AA, Haigentz M Jr, Rinaldo A, Rodrigo JP, Saba NF, Suárez C, Vermorken JB, Ferlito A.

Head Neck. 2017 Nov;39(11):2329-2349. doi: 10.1002/hed.24883. Epub 2017 Aug 17. Review.

Supplemental Content

Loading ...
Support Center